{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T05:48:22Z","timestamp":1771739302198,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000},"content-version":"vor","delay-in-days":3547,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA-72319"],"award-info":[{"award-number":["CA-72319"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK-40247"],"award-info":[{"award-number":["DK-40247"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.2353\/ajpath.2010.090684","type":"journal-article","created":{"date-parts":[[2010,3,26]],"date-time":"2010-03-26T22:25:17Z","timestamp":1269642317000},"page":"2320-2332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Suppressor of Cytokine Signaling-2 Gene Disruption Promotes ApcMin\/+ Tumorigenesis and Activator Protein-1 Activation"],"prefix":"10.1016","volume":"176","author":[{"given":"Victoria A.","family":"Newton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole M.","family":"Ramocki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooks P.","family":"Scull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirk","family":"McNaughton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Kay","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2010.090684_bib10","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1053\/gast.2002.37068","article-title":"Suppressors of cytokine signaling: relevance to gastrointestinal function and disease","volume":"123","author":"Greenhalgh","year":"2002","journal-title":"Gastroenterology"},{"key":"10.2353\/ajpath.2010.090684_bib20","doi-asserted-by":"crossref","first-page":"6613","DOI":"10.1038\/sj.onc.1204086","article-title":"STAT proteins: novel molecular targets for cancer drug discovery","volume":"19","author":"Turkson","year":"2000","journal-title":"Oncogene"},{"key":"10.2353\/ajpath.2010.090684_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1172\/JCI200522710","article-title":"SOCS2 negatively regulates growth hormone action in vitro and in vivo","volume":"115","author":"Greenhalgh","year":"2005","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2010.090684_bib40","doi-asserted-by":"crossref","first-page":"G472","DOI":"10.1152\/ajpgi.00218.2005","article-title":"Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo","volume":"291","author":"Michaylira","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.2353\/ajpath.2010.090684_bib50","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1053\/j.gastro.2004.05.016","article-title":"Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation","volume":"127","author":"Miller","year":"2004","journal-title":"Gastroenterology"},{"key":"10.2353\/ajpath.2010.090684_bib60","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1210\/en.2005-1241","article-title":"Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgene mice","volume":"147","author":"Michaylira","year":"2006","journal-title":"Endocrinology"},{"key":"10.2353\/ajpath.2010.090684_bib70","first-page":"93","article-title":"Management of colorectal polyps","volume":"47","author":"Markowitz","year":"1997","journal-title":"CA Cancer J Clin"},{"key":"10.2353\/ajpath.2010.090684_bib80","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1158\/1055-9965.882.13.5","article-title":"Methylated DNA collected by tampons\u2014a new tool to detect endometrial cancer","volume":"13","author":"Fiegl","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.2353\/ajpath.2010.090684_bib90","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/sj.jid.5700073","article-title":"Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma","volume":"126","author":"Marini","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.2353\/ajpath.2010.090684_bib100","doi-asserted-by":"crossref","first-page":"7726","DOI":"10.1038\/sj.onc.1207787","article-title":"Differential hypermethylation of SOCS genes in ovarian and breast carcinomas","volume":"23","author":"Sutherland","year":"2004","journal-title":"Oncogene"},{"key":"10.2353\/ajpath.2010.090684_bib110","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/jcp.2004.024919","article-title":"Suppressor of cytokine signaling 2 (SOCS-2) expression in breast carcinoma","volume":"58","author":"Farabegoli","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.2353\/ajpath.2010.090684_bib120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1053\/j.gastro.2006.05.030","article-title":"SOC-ing it to tumors: tumor suppressors of cytokine signaling as tumor repressors","volume":"131","author":"Lund","year":"2006","journal-title":"Gastroenterology"},{"key":"10.2353\/ajpath.2010.090684_bib130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-2407-7-136","article-title":"Favorable prognostic value of SOCS2 and IGF-I in breast cancer","volume":"7","author":"Haffner","year":"2007","journal-title":"BMC Cancer"},{"key":"10.2353\/ajpath.2010.090684_bib140","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1349-7006.2006.00190.x","article-title":"Mouse models of gastrointestinal tumors","volume":"97","author":"Taketo","year":"2006","journal-title":"Cancer Sci"},{"key":"10.2353\/ajpath.2010.090684_bib150","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1126\/science.1350108","article-title":"Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene","volume":"256","author":"Su","year":"1992","journal-title":"Science"},{"key":"10.2353\/ajpath.2010.090684_bib160","doi-asserted-by":"crossref","first-page":"17751","DOI":"10.1074\/jbc.M600831200","article-title":"Adenomatous polyposis coli (APC) differentially regulates \u03b2-catenin phosphorylation and ubiquitination in colon cancer cells","volume":"281","author":"Yang","year":"2006","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2010.090684_bib170","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1254\/jphs.08193FP","article-title":"Inhibition of peroxisome proliferator-activated receptor \u03b3 promotes tumorigenesis through activation of the \u03b2-catenin\/T cell factor (TCF) pathway in the mouse intestine","volume":"108","author":"Fujisawa","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.2353\/ajpath.2010.090684_bib180","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/138945008784221116","article-title":"Signaling molecules: the pathogenic role of the IL-6\/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer","volume":"9","author":"Atreya","year":"2008","journal-title":"Curr Drug Targets"},{"key":"10.2353\/ajpath.2010.090684_bib190","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1074\/jbc.M608952200","article-title":"Ras\/ERK1\/2-mediated STAT3 Ser727 phosphorylation by familial medullary thyroid carcinoma-associated RET mutants induces full activation of STAT3 and is required for c-fos promoter activation, cell mitogenicity, and transformation","volume":"282","author":"Plaza-Menacho","year":"2007","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2010.090684_bib200","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1038\/sj.onc.1210567","article-title":"Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity","volume":"26","author":"Lufei","year":"2007","journal-title":"Oncogene"},{"key":"10.2353\/ajpath.2010.090684_bib210","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/dna.2008.0762","article-title":"Ha-ras oncogene-induced Stat3 phosphorylation enhances oncogenicity of the cell","volume":"28","author":"Yeh","year":"2009","journal-title":"DNA Cell Biol"},{"key":"10.2353\/ajpath.2010.090684_bib220","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/35016611","article-title":"Gigantism in mice lacking suppressor of cytokine signalling-2","volume":"405","author":"Metcalf","year":"2000","journal-title":"Nature"},{"key":"10.2353\/ajpath.2010.090684_bib230","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1073\/pnas.032678499","article-title":"Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis","volume":"99","author":"Roberts","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2010.090684_bib240","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1126\/science.2296722","article-title":"A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse","volume":"247","author":"Moser","year":"1990","journal-title":"Science"},{"key":"10.2353\/ajpath.2010.090684_bib250","series-title":"Guide for the Care and Use of Laboratory Animals","author":"Institute of Laboratory Animal Resources","year":"1996"},{"key":"10.2353\/ajpath.2010.090684_bib260","first-page":"1070","article-title":"Insulin-like growth factor II supply modifies growth of intestinal adenoma in ApcMin\/+ mice","volume":"60","author":"Hassan","year":"2000","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.090684_bib270","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF01920745","article-title":"AKS: Differential removal of insulin-like growth factor binding proteins in rat serum by solvent extraction procedures","volume":"50","author":"Srivenugopal","year":"1994","journal-title":"Experientia"},{"key":"10.2353\/ajpath.2010.090684_bib280","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0197-4580(01)00240-8","article-title":"Effect of age and cognitive status on basal level AP-1 activity in rat hippocampus","volume":"22","author":"Smith","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.2353\/ajpath.2010.090684_bib290","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1096\/fj.04-3274fje","article-title":"Targeting the \u03b2-catenin\/APC pathway: a novel mechanism to explain the cyclooxygenase-2-independent anticarcinogenic effects of celecoxib in human colon carcinoma cells","volume":"19","author":"Maier","year":"2005","journal-title":"FASEB J"},{"key":"10.2353\/ajpath.2010.090684_bib300","first-page":"1157","article-title":"Insulin-like growth factor-i and epidermal growth factor interact to regulate growth and gene expression in IEC-6 intestinal epithelial cells","volume":"9","author":"Simmons","year":"1995","journal-title":"Mol Endocrinol"},{"key":"10.2353\/ajpath.2010.090684_bib310","first-page":"F25","article-title":"Studies of neoplasia in the Min mouse","volume":"1332","author":"Shoemaker","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.2353\/ajpath.2010.090684_bib320","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/gut.2006.111633","article-title":"Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett's adenocarcinoma","volume":"56","author":"Tischoff","year":"2007","journal-title":"Gut"},{"key":"10.2353\/ajpath.2010.090684_bib330","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1002\/ijc.23805","article-title":"Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme","volume":"123","author":"Martini","year":"2008","journal-title":"Int J Cancer"},{"key":"10.2353\/ajpath.2010.090684_bib340","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1158\/1078-0432.CCR-06-2303","article-title":"Reciprocal regulation of SOCS1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme","volume":"13","author":"Zhou","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.2353\/ajpath.2010.090684_bib350","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1053\/j.gastro.2006.04.025","article-title":"Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis","volume":"131","author":"Ogata","year":"2006","journal-title":"Gastroenterology"},{"key":"10.2353\/ajpath.2010.090684_bib360","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1038\/sj.onc.1210286","article-title":"Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon","volume":"26","author":"Rigby","year":"2007","journal-title":"Oncogene"},{"key":"10.2353\/ajpath.2010.090684_bib370","doi-asserted-by":"crossref","first-page":"29912","DOI":"10.1074\/jbc.M504516200","article-title":"Functional significance of type 1 insulin-like growth factor-mediated nuclear translocation of the insulin receptor substrate-1 and \u03b2-catenin","volume":"280","author":"Chen","year":"2005","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2010.090684_bib380","doi-asserted-by":"crossref","first-page":"12103","DOI":"10.1073\/pnas.210394297","article-title":"Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of \u03b2-catenin","volume":"97","author":"Playford","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2010.090684_bib390","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ejca.2005.08.016","article-title":"The role of IL-6 and STAT3 in inflammation and cancer","volume":"41","author":"Hodge","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.2353\/ajpath.2010.090684_bib400","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ccr.2009.01.001","article-title":"IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer","volume":"15","author":"Grivennikov","year":"2009","journal-title":"Cancer Cell"},{"key":"10.2353\/ajpath.2010.090684_bib410","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2009.01.002","article-title":"gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis","volume":"15","author":"Bollrath","year":"2009","journal-title":"Cancer Cell"},{"key":"10.2353\/ajpath.2010.090684_bib420","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1053\/j.gastro.2009.11.049","article-title":"Stat3 is a negative regulator of intestinal tumor progression in ApcMin mice","volume":"138","author":"Musteanu","year":"2009","journal-title":"Gastroenterology"},{"key":"10.2353\/ajpath.2010.090684_bib430","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1210\/endo.138.10.5266","article-title":"Signal-transducer and activator of transcription-3 serine phosphorylation by insulin is mediated by a Ras\/Raf\/MEK-dependent pathway","volume":"138","author":"Ceresa","year":"1997","journal-title":"Endocrinology"},{"key":"10.2353\/ajpath.2010.090684_bib440","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11259-006-3330-4","article-title":"Immunohistochemical study of phospho-Stat3-ser727 expression in feline mammary gland tumours","volume":"31","author":"Petterino","year":"2007","journal-title":"Vet Res Commun"},{"key":"10.2353\/ajpath.2010.090684_bib450","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.1158\/0008-5472.CAN-08-1125","article-title":"Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation","volume":"68","author":"Qin","year":"2008","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.090684_bib460","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/MCB.24.1.407-419.2004","article-title":"Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation","volume":"24","author":"Shen","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.2353\/ajpath.2010.090684_bib470","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1038\/sj.onc.1202238","article-title":"Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK)","volume":"17","author":"Jain","year":"1998","journal-title":"Oncogene"},{"key":"10.2353\/ajpath.2010.090684_bib480","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1128\/MCB.17.11.6508","article-title":"Stat3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation","volume":"17","author":"Chung","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.2353\/ajpath.2010.090684_bib490","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1093\/nar\/25.11.2062","article-title":"Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3","volume":"25","author":"Wen","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"10.2353\/ajpath.2010.090684_bib500","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1042\/bj20020295","article-title":"Biphasic regulation of extracellular-signal-regulated protein kinase by leptin in macrophages: role in regulating STAT3 Ser727 phosphorylation and DNA binding","volume":"364","author":"O'Rourke","year":"2002","journal-title":"Biochem J"},{"key":"10.2353\/ajpath.2010.090684_bib510","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cellsig.2009.02.009","article-title":"SH2B1\u03b2 enhances fibroblast growth factor 1 (FGF1)-induced neurite outgrowth through MEK-ERK1\/2-STAT3-Egr1 pathway","volume":"21","author":"Lin","year":"2009","journal-title":"Cell Signal"},{"key":"10.2353\/ajpath.2010.090684_bib520","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.alcohol.2008.02.004","article-title":"Ethanol inhibition of angiotensin II-stimulated Tyr705 and Ser727 STAT3 phosphorylation in cultured rat hepatocytes: relevance to activation of p42\/44 mitogen-activated protein kinase","volume":"42","author":"Weng","year":"2008","journal-title":"Alcohol"},{"key":"10.2353\/ajpath.2010.090684_bib530","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1038\/onc.2008.211","article-title":"The role of the transcription factor AP-1 in colitis-associated and \u03b2-catenin-dependent intestinal tumorigenesis in mice","volume":"27","author":"Hasselblatt","year":"2008","journal-title":"Oncogene"},{"key":"10.2353\/ajpath.2010.090684_bib540","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/emboj.2009.153","article-title":"JNK signaling modulates intestinal homeostatis and tumorigenesis in mice","volume":"28","author":"Sancho","year":"2009","journal-title":"EMBO J"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010600284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010600284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:46:55Z","timestamp":1762080415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010600284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0002944010600284"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2010.090684","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppressor of Cytokine Signaling-2 Gene Disruption Promotes ApcMin\/+ Tumorigenesis and Activator Protein-1 Activation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.2353\/ajpath.2010.090684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}